Medtech Archives - Page 102 of 103

Takeda Reports Breakthrough Phase 3 Results for Oveporexton in Narcolepsy Type 1

July 14, 2025

Early Study of Angelman Syndrome Drug Rugonersen Shows Promise, Published in Nature Medicine

July 11, 2025

SharkNinja Names Former Amazon Executive Mike Harris as Chief Innovation and Technology Officer

July 10, 2025

THIS WEEK'S STORIES

PursueCare to Highlight Digital Addiction Treatment Model at 2025 BHB Addiction Treatment Forum

July 14, 2025

Waters Acquires Halo Labs to Strengthen Biologic Therapy Testing Capabilities

July 14, 2025

SharkNinja Names Former Amazon Executive Mike Harris as Chief Innovation and Technology Officer

July 10, 2025

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Medtech

LivsMed Unveils STARK Robotic System with Telesurgery Capabilities, Partnering with Sovato to Expand Remote Surgical Access

HistoSonics Expands Insurance Coverage for Non-Invasive Liver Tumor Treatment to 7 Million Highmark Members

BEAR Implant Shows Promising ACL Repair Results in Real-World Study, Miach Orthopaedics Reports at AOSSM 2025

PharmaJet Signs Agreement with Egyptian Authorities and EVA Pharma to Introduce Needle-Free Vaccination in Egypt

First Patients Enrolled in Study Testing Non-Invasive Tool to Improve Atrial Fibrillation Treatment

Most Read

Waters Acquires Halo Labs to Strengthen Biologic Therapy Testing Capabilities

FDA Approves Bayer’s KERENDIA® for Heart Failure Patients With Preserved Ejection Fraction

Kenvue Appoints Kirk Perry as Interim CEO, Launches Strategic Review to Unlock Shareholder Value

LivsMed Unveils STARK Robotic System with Telesurgery Capabilities, Partnering with Sovato to Expand Remote Surgical Access

EDITOR PICKS

Takeda Reports Breakthrough Phase 3 Results for Oveporexton in Narcolepsy Type 1

Early Study of Angelman Syndrome Drug Rugonersen Shows Promise, Published in Nature Medicine

SharkNinja Names Former Amazon Executive Mike Harris as Chief Innovation and Technology Officer

THIS WEEK'S STORIES

PursueCare to Highlight Digital Addiction Treatment Model at 2025 BHB Addiction Treatment Forum

Waters Acquires Halo Labs to Strengthen Biologic Therapy Testing Capabilities

SharkNinja Names Former Amazon Executive Mike Harris as Chief Innovation and Technology Officer

POPULAR CATEGORY

ABOUT US

FOLLOW US